Open AccessCandida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients
Author(s) -
Maria Aigner,
Marina Wanner,
P Kreidl,
Cornelia LassFlörl,
Michaela Lackner
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00138-19
Subject(s) - galactomannan , candida glabrata , aspergillosis , microbiology and biotechnology , biology , medicine , mycosis , respiratory tract , candida infections , critically ill , gastroenterology , immunology , respiratory system , candida albicans
BAL fluid samples from critically ill patients shared a rate of 29% false-positive galactomannan results. We aimed to determine whetherCandida species abundance in BAL fluid causes galactomannan (GM) positivity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom